Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Classified as a selective Nicotinamide N-methyltransferase (NNMT) small-molecule inhibitor, this quaternary ammonium compound achieves around 38.4% oral bioavailability in rodent trials, an acceptable absorption rate for positively charged quinolinium derivatives that typically face poor intestinal permeability
What the human evidence looks like How many human studies exist The 2025 systematic review by Vasireddi, Hahamyan, Salata, and colleagues in HSS Journal is the most rigorous available assessment of the BPC-157 literature (19932024) for orthopedic and sports medicine applications
On NAD+, the brand offers three delivery formats, each with a different brand-stated tradeoff: Injection: what the brand calls the highest bioavailability Oral liquid drops: positioned for at-home convenience Nasal spray: a middle ground the brand associates with potential cognitive benefits The brand states that "many patients report" energy improvements and mental clarity within the first week of injectable NAD+ - again, a brand-reported patient experience, not an independently audited result
The prodrug was stable in normal tissues but can be easily hydrolyzed into DON in P493B lymphoma cells, inhibiting tumor cell proliferation in a dose-dependent manner (Tenora et al., 2019)
Nurses should check that patients understand the chronic nature of treatment
US$ 20.37
US$ 25.05
US$ 27.42
US$ 27.80
US$ 24.63
